PCN45 UK COST-EFFECTIVENESS ANALYSES OF DOCETAXEL VERSUS GENERIC PACLITAXEL ONCE WEEKLY AND NAB-PACLITAXEL IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER (MBC) PROGRESSED AFTERANTHRACYCLINE CHEMOTHERAPY
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65203-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65203-5/fulltext
Title :
PCN45 UK COST-EFFECTIVENESS ANALYSES OF DOCETAXEL VERSUS GENERIC PACLITAXEL ONCE WEEKLY AND NAB-PACLITAXEL IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER (MBC) PROGRESSED AFTERANTHRACYCLINE CHEMOTHERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65203-5&doi=10.1016/S1098-3015(10)65203-5
First page :
Section Title :
Open access? :
No
Section Order :
362